Cargando…
Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study
BACKGROUND: An absence of screening recommendations and the rapid progression of testicular germ cell tumours (TGCTs) offer a perspective on the potential impact of the COVID-19 pandemic on cancer presentations. We evaluated the presenting cancer stages of TGCTs in a real-world population before and...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262347/ https://www.ncbi.nlm.nih.gov/pubmed/35790231 http://dx.doi.org/10.9778/cmajo.20210285 |
_version_ | 1784742474115186688 |
---|---|
author | Lee-Ying, Richard O’Sullivan, Dylan E. Gagnon, Richard Bosma, Nicholas Stewart, Rebecca N. Railton, Cindy Tilley, Derek Alimohamed, Nimira Basappa, Naveen Cheng, Tina Kolinsky, Michael Karim, Safiya Ruether, Dean North, Scott Yip, Steven Danielson, Brita Heng, Daniel Brenner, Darren |
author_facet | Lee-Ying, Richard O’Sullivan, Dylan E. Gagnon, Richard Bosma, Nicholas Stewart, Rebecca N. Railton, Cindy Tilley, Derek Alimohamed, Nimira Basappa, Naveen Cheng, Tina Kolinsky, Michael Karim, Safiya Ruether, Dean North, Scott Yip, Steven Danielson, Brita Heng, Daniel Brenner, Darren |
author_sort | Lee-Ying, Richard |
collection | PubMed |
description | BACKGROUND: An absence of screening recommendations and the rapid progression of testicular germ cell tumours (TGCTs) offer a perspective on the potential impact of the COVID-19 pandemic on cancer presentations. We evaluated the presenting cancer stages of TGCTs in a real-world population before and during the pandemic to assess stage migration. METHODS: We performed a retrospective review of all new patients with TGCT diagnoses in Alberta, Canada, from Dec. 31, 2018, to Apr. 30, 2021, using the Alberta Cancer Registry. Because potential changes in staging should not occur instantaneously, we used a 6-month lag time from Apr. 1, 2020, for seminomas, and a 3-month lag time for nonseminomas, to compare initial cancer stages at presentation before and during the pandemic. We evaluated monthly rates of presentation by stage and histology. Exploratory outcomes included the largest tumour dimension, tumour markers and, for advanced disease, risk category and treatment setting. RESULTS: Of 335 patients with TGCTs, 231 were diagnosed before the pandemic and 104 during the pandemic (using a lag time). In total, 18 (7.8%) patients diagnosed before the pandemic presented with stage III disease, compared to 16 (15.4%) diagnosed during the pandemic (relative risk 1.97, 95% confidence interval [CI] 1.05–3.72). We observed no significant differences for secondary outcomes. Without a lag time, the rate ratio for a stage II presentation decreased significantly during the pandemic (0.40, 95% CI 0.21–0.72). INTERPRETATION: We observed signs of TGCT stage migration during the COVID-19 pandemic, driven by a decline in stage II disease and a potential rise in stage III disease. Management of TGCTs should remain a priority, even during a global pandemic. |
format | Online Article Text |
id | pubmed-9262347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | CMA Impact Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92623472022-07-10 Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study Lee-Ying, Richard O’Sullivan, Dylan E. Gagnon, Richard Bosma, Nicholas Stewart, Rebecca N. Railton, Cindy Tilley, Derek Alimohamed, Nimira Basappa, Naveen Cheng, Tina Kolinsky, Michael Karim, Safiya Ruether, Dean North, Scott Yip, Steven Danielson, Brita Heng, Daniel Brenner, Darren CMAJ Open Research BACKGROUND: An absence of screening recommendations and the rapid progression of testicular germ cell tumours (TGCTs) offer a perspective on the potential impact of the COVID-19 pandemic on cancer presentations. We evaluated the presenting cancer stages of TGCTs in a real-world population before and during the pandemic to assess stage migration. METHODS: We performed a retrospective review of all new patients with TGCT diagnoses in Alberta, Canada, from Dec. 31, 2018, to Apr. 30, 2021, using the Alberta Cancer Registry. Because potential changes in staging should not occur instantaneously, we used a 6-month lag time from Apr. 1, 2020, for seminomas, and a 3-month lag time for nonseminomas, to compare initial cancer stages at presentation before and during the pandemic. We evaluated monthly rates of presentation by stage and histology. Exploratory outcomes included the largest tumour dimension, tumour markers and, for advanced disease, risk category and treatment setting. RESULTS: Of 335 patients with TGCTs, 231 were diagnosed before the pandemic and 104 during the pandemic (using a lag time). In total, 18 (7.8%) patients diagnosed before the pandemic presented with stage III disease, compared to 16 (15.4%) diagnosed during the pandemic (relative risk 1.97, 95% confidence interval [CI] 1.05–3.72). We observed no significant differences for secondary outcomes. Without a lag time, the rate ratio for a stage II presentation decreased significantly during the pandemic (0.40, 95% CI 0.21–0.72). INTERPRETATION: We observed signs of TGCT stage migration during the COVID-19 pandemic, driven by a decline in stage II disease and a potential rise in stage III disease. Management of TGCTs should remain a priority, even during a global pandemic. CMA Impact Inc. 2022-07-05 /pmc/articles/PMC9262347/ /pubmed/35790231 http://dx.doi.org/10.9778/cmajo.20210285 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Research Lee-Ying, Richard O’Sullivan, Dylan E. Gagnon, Richard Bosma, Nicholas Stewart, Rebecca N. Railton, Cindy Tilley, Derek Alimohamed, Nimira Basappa, Naveen Cheng, Tina Kolinsky, Michael Karim, Safiya Ruether, Dean North, Scott Yip, Steven Danielson, Brita Heng, Daniel Brenner, Darren Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study |
title | Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study |
title_full | Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study |
title_fullStr | Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study |
title_full_unstemmed | Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study |
title_short | Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study |
title_sort | stage migration of testicular germ cell tumours in alberta, canada, during the covid-19 pandemic: a retrospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262347/ https://www.ncbi.nlm.nih.gov/pubmed/35790231 http://dx.doi.org/10.9778/cmajo.20210285 |
work_keys_str_mv | AT leeyingrichard stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT osullivandylane stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT gagnonrichard stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT bosmanicholas stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT stewartrebeccan stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT railtoncindy stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT tilleyderek stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT alimohamednimira stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT basappanaveen stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT chengtina stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT kolinskymichael stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT karimsafiya stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT ruetherdean stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT northscott stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT yipsteven stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT danielsonbrita stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT hengdaniel stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy AT brennerdarren stagemigrationoftesticulargermcelltumoursinalbertacanadaduringthecovid19pandemicaretrospectivecohortstudy |